⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4405927 | 0.74 | — | — | |
| SCHEMBL4562799 | 0.72 | — | — | |
| SCHEMBL3635796 | 0.71 | — | — | |
| SCHEMBL278124 | 0.71 | — | — | |
| SCHEMBL8642386 | 0.69 | LMNA (0.32) | — | |
| SCHEMBL592111 | 0.67 | — | — | |
| SCHEMBL471880 | 0.67 | — | — | |
| Bicarbonate SCHEMBL28615380 | 0.67 | LMNA (0.32) | — | |
| SCHEMBL4665260 | 0.67 | — | — | |
| SCHEMBL2989676 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0831770-B1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMA (US) | 2000-08-16 | — | — | EP | claimed |
| EP-0655069-B1 | AMPHIPHILIC COMPOUNDS DERIVED FROM AMINO ACIDS OR PEPTIDES, THEIR METHODS OF SYNTHESIS AND THEIR APPLICATION AS DRUG DELIVERY SYSTEMS | ALLIANCE PHARMA (US) | 1999-11-03 | — | — | EP | claimed |
| EP-0666736-B1 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMA (US) | 1996-12-18 | — | — | EP | claimed |
| EP-0655069-A1 | AMPHIPHILIC COMPOUNDS DERIVED FROM AMINO ACIDS OR PEPTIDES, THEIR METHODS OF SYNTHESIS AND THEIR APPLICATION AS DRUG DELIVERY SYSTEMS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1995-05-31 | — | — | EP | claimed |
| WO-1994003468-A1 | AMPHIPHILIC COMPOUNDS DERIVED FROM AMINO ACIDS OR PEPTIDES, THEIR METHODS OF SYNTHESIS AND THEIR APPLICATION AS DRUG DELIVERY SYSTEMS | S.A. A.T.T.A. APPLICATIONS ET TRANSFERTS DE TECHNOLOGIES AVANCEES (FR) | 1994-02-17 | — | — | WO | claimed |
| US-8748497-B2 | Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses | ALLIANCE PHARMACEUTICAL CORP. (US) | 2014-06-10 | — | — | US | disclosed |
| EP-1740189-B1 | LUNG SURFACTANT SUPPLEMENTS | CENTRE NAT RECH SCIENT (FR) | 2012-06-13 | — | — | EP | disclosed |
| US-20100298445-A1 | Optimized Fluorocarbon Emulsions for Blood Substitutes and Other Therapeutic Uses | ALLIANCE PHARMACEUTICAL CORP | 2010-11-25 | — | — | US | disclosed |
| EP-2034959-A2 | OPTIMIZED FLUOROCARBON EMULSIONS FOR BLOOD SUBSTITUTES AND OTHER THERAPEUTIC USES | Alliance Pharmaceutical Corp (US) | 2009-03-18 | — | — | EP | disclosed |
| US-20080019926-A1 | Lung Surfactant Supplements | UNIVERSITE LOUIS PASTEUR INDUSTRIE (FR) | 2008-01-24 | — | — | US | disclosed |
| WO-2007139827-A2 | OPTIMIZED FLUOROCARBON EMULSIONS FOR BLOOD SUBSTITUTES AND OTHER THERAPEUTIC USES | ALLIANCE PHARMACEUTICAL CORP. (US) | 2007-12-06 | — | — | WO | disclosed |
| US-20050256211-A9 | Patient oxygenation using stabilized fluorocarbon emulsions | PFC THERAPEUTICS, LLC | 2005-11-17 | — | — | US | disclosed |
| US-20040068020-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2004-04-08 | — | — | US | disclosed |
| US-20020065326-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2002-05-30 | — | — | US | disclosed |
| US-6204296-B1 | INTRAVENOUSLY ADMINISTERING TO SAID PATIENT A FLUOROCARBON EMULSION COMPRISING AN EMULSIFYING AGENT, PERFLUOROOCTYL BROMIDE AND PERFLUORODECYL BROMIDE. | ALLIANCE PHARMACEUTICAL CORP. | 2001-03-20 | — | — | US | disclosed |
| EP-0689422-B1 | FLUOROCARBON EMULSIONS WITH REDUCED PULMONARY GAS-TRAPPING PROPERTIES | ALLIANCE PHARMA (US) | 1999-07-14 | — | — | EP | disclosed |
| US-5914352-A | Methods for the use of stabilized fluorocarbon emulsions | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-06-22 | — | — | US | disclosed |
| US-5635538-A | AQUEOUS PHASE, EMULSIFYING AGENT, AND LIQUID FLUOROCARBON PHASE CONTAINING MIXTURE OF AT LEAST TWO FLUOROCARBONS, AT LEAST ONE FLUOROCARBON HAS COVALENTLY ATTACHED LIPOPHILIC MOIETY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5628930-A | STORAGE STABILITY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0666736-B1 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMA (US) | 1996-12-18 | — | — | EP | disclosed |